Here is the latest stock price and chart of Divis Laboratories. For more details, see the Divis Laboratories company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.
Know More: Which way are the markets & the mutual fund industry headed?
Live BSE Quotes | Jan 27, 2021 (Close) | ||
---|---|---|---|
Price (Rs)3,483.90 | Open (Rs) 3,600.00 | High (Rs) 3,600.00 | Low (Rs) 3,469.50 |
% Change-2.43 | Volume 33,052 | Value (Rs) 115,903,173 | 52-Week H/L 3,913.00 / 1,632.70 |
Live NSE Quotes | Jan 27, 2021 (Close) | ||
---|---|---|---|
Price (Rs)3,483.05 | Open (Rs) 3,594.90 | High (Rs) 3,600.00 | Low (Rs) 3,469.90 |
% Change-2.41 | Volume 944,951 | Value (Rs) 3,291,311,581 | 52-Week H/L 3,914.95 / 1,626.00 |
Change | |||||
---|---|---|---|---|---|
1 Day -2.43% | 1 Month -7.46% | 3 Months 10.38% | 1 Year 81.67% | 5 Years (CAGR)* 24.96% | 10 Years (CAGR)* 27.43% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 60.33 | P/E Ratio (x) 57.75 | Market Cap (Rs m) 924,863.97 | P/BV (x) 13.31 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
DIVIS LABORATORIES last traded price was down 2.4% to Rs 3,483.9 on the BSE. On the NSE, DIVIS LABORATORIES last traded price was down 2.4% to Rs 3,483.1. The total volume of shares traded was 1.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 1.7%. And the benchmark S&P BSE SENSEX was at 47,409.9 (down 1.9%).
Over the last 30 days, the DIVIS LABORATORIES share price is down 7.5%. And over the last one year, DIVIS LABORATORIES share price is up 81.7%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed heavy selling pressure today despite the US administration saying it would bring a stimulus package even without the opposition's support.
For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More